Analyzing the permissible scope of an injunction under the Hatch-Waxman Act, the US Court of Appeals for the Federal Circuit reversed the ...

As the FDA prepares for a busy Oncologic Drugs Advisory Committee next week, an agency insider told BioSpace that volunteers ...

- First ASXL1 Pediatric Acute Myeloid Leukemia (AML) Patient Dosed at MD Anderson Cancer Center: Program Supported by Rare Pediatric Disease Designation (RPDD) ...

A low dose combination hormonal patch was found to be effective for pregnancy prevention based on results from a phase 3 study.

On Thursday, 2637 stocks advanced, 1327 declined and 151 remained unchanged on Bombay Stock Exchange with advance decline ...

CING READ THE FULL CING RESEARCH REPORT Cingulate, Inc. (NASDAQ:CING) reported first quarter 2025 results on May 8 th , 2025.

Lupin receives US FDA approval for rivaroxaban tablets USP, 10 mg, 15 mg & 20 mg: Our Bureau, Mumbai Thursday, May 15, 2025, 15:40 Hrs [IST] Global pharma major Lupin Limited (Lup ...

Vadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug ...